Trial suggests imaging is better than clinical examination for determining response to chemotherapy

摘要

A trial that used MRI to measure the progress of chemotherapy used to treat breast cancer has suggested that imaging might provide useful information about the patient's response to the treatment. The study, published in the journal Radiology, looked at using MRI to judge a patient's response to neoadjuvant chemotherapy, suggesting that it is better than current clinical techniques.